Testing lower doses of febuxostat in well-controlled gout
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 to 79 years old
- You have taken a gout medication like allopurinol or febuxostat for at least 5 years
- Your uric acid levels have stayed below 6.0 mg/dL for the past 5 years, or the overall pattern was very low
- You do not have any tophi (hard lumps under the skin from gout) that can be felt or seen
- You have not had a gout flare or kidney stone in the last year
- Your kidney function is good (eGFR of 60 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This Phase 3 study compares starting febuxostat immediately during a gout flare versus delaying the start. It aims to see which timing helps control gout better and safely.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study compares two medicines—metformin (usually for diabetes) and febuxostat (for gout)—in people who have both gout and obesity but not diabetes. The goal is to see which works better for controlling gout and related health markers.
This study tests whether a pharmacist-led program can help veterans with gout better manage their uric acid levels using common medications like allopurinol or febuxostat. If you have had a gout flare in the last 6 months and are already taking or starting a urate-lowering medication, this trial may be for you.
This trial studies whether allopurinol can reduce the chance of cardiovascular events like heart attack, stroke, or related problems in people who are at higher risk. It targets people with higher uric acid and other risk factors, to see if lowering uric acid helps protect the heart.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.